Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 236 (RN7SKP236) is a pseudogene that shares sequence similarity to the functional 7SK RNA gene (RN7SK). The 7SK RNA itself is a highly abundant small nuclear noncoding RNA which participates in the regulation of transcription elongation by interacting with and modulating the activity of the positive transcription elongation factor P-TEFb in complex with multiple RNA-binding proteins[1][2]. While the functional 7SK RNA has important regulatory and developmental roles, a "pseudogene" like RN7SKP236 is defined as a non-functional segment of DNA resembling an active gene, usually due to mutations or lack of regulatory elements required for expression[3][4]. There is no evidence that RN7SKP236 produces a functional RNA or protein product, nor is it classified as a drug target, receptor, enzyme, or other conventional therapeutic target. Key clarifications: - RN7SKP236 is a pseudogene, not a functional gene or receptor[3][4]. - It does not encode a protein or act as a classical biological target. - No evidence supports drug interactions, disease association, or biomarker roles for this specific pseudogene. - It should not be confused with the functional 7SK RNA (RN7SK), which plays a crucial role in transcriptional regulation[1][2]. If you seek structured information on the functional 7SK RNA (RN7SK), please clarify—the above data reflects the status of the pseudogene RN7SKP236.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 236 (RN7SKP236).